| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Department of Pediatrics, Oregon Health Sciences University, Portland, Oregon 97201
Address all correspondence and requests for reprints to: Ron G. Rosenfeld, M.D., Department of Pediatrics, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97201. E-mail: rosenfer{at}ohsu.edu
Abstract
Neuroendocrine cells have been implicated in many cancers, including small cell lung, cervical, breast, and prostate carcinomas. The increase in neuroendocrine cell number in prostate cancer has been reported to correlate with poor prognosis, progressive tumors, and androgen insensitivity. The mechanisms involved in this differentiation remain unknown. IGF-binding protein-related protein 1 is a member of the IGF-binding protein superfamily and has recently been shown to exhibit differentiation and tumor suppression activity in prostate cancer cell lines stably overexpressing IGF-binding protein-related protein 1. From a yeast two-hybrid screen, a novel IGF-binding protein-related protein 1-interacting protein was identified. Immunocytochemical techniques indicate that this protein, 25.1, and intracellular IGF-binding protein-related protein 1 colocalize in the nucleus. When 25.1 is transiently expressed in a stable prostate cancer cell line overexpressing IGF-binding protein-related protein 1, cells assume a neuritic-like morphology with long dendritic-like processes and express the neuroendocrine markers chromogranin A and neuron-specific enolase. We propose that 25.1 (neuroendocrine differentiation factor) together with IGF-binding protein-related protein 1 can induce neuroendocrine cell differentiation in prostate cancer cells.
This article has been cited by other articles:
![]() |
M. Kutsukake, R. Ishihara, M. Yoshie, H. Kogo, and K. Tamura Involvement of insulin-like growth factor-binding protein-related protein 1 in decidualization of human endometrial stromal cells Mol. Hum. Reprod., October 1, 2007; 13(10): 737 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salido, J. L. Gonzalez, and J. Vilches Loss of mitochondrial membrane potential is inhibited by bombesin in etoposide-induced apoptosis in PC-3 prostate carcinoma cells Mol. Cancer Ther., April 1, 2007; 6(4): 1292 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fang, E. M. Kofoed, B. M. Little, X. Wang, R. J. M. Ross, S. J. Frank, V. Hwa, and R. G. Rosenfeld A Mutant Signal Transducer and Activator of Transcription 5b, Associated with Growth Hormone Insensitivity and Insulin-Like Growth Factor-I Deficiency, Cannot Function as a Signal Transducer or Transcription Factor J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1526 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hwa, B. Little, E. M. Kofoed, and R. G. Rosenfeld Transcriptional Regulation of Insulin-like Growth Factor-I by Interferon-{gamma} Requires STAT-5b J. Biol. Chem., January 23, 2004; 279(4): 2728 - 2736. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Diaz, Y. H. Yang, T. Ferreira, K. C. Loh, Y. Okazaki, Y. Hayashizaki, M. Tessier-Lavigne, T. P. Speed, and J. Ngai Analysis of gene expression in the developing mouse retina PNAS, April 29, 2003; 100(9): 5491 - 5496. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |